Safety and Feasibility of Minimally Invasive (Laparoscopic/Robotic-Assisted) Nipple-Sparing Mastectomy Combined with Prosthesis Breast Reconstruction in Breast Cancer: A Single-Center Retrospective Study

医学 单中心 乳房再造术 乳房切除术 腹腔镜检查 外科 乳腺癌 假肢 外科肿瘤学 回顾性队列研究 癌症 内科学
作者
Yu Gui,Qingqiu Chen,Shichao Li,X. Jessie Yang,Jing Liu,Xin Wu,Yilin Zhu,Linjun Fan,Jun Jiang,Li Chen
出处
期刊:Annals of Surgical Oncology [Springer Nature]
卷期号:29 (7): 4057-4065 被引量:10
标识
DOI:10.1245/s10434-022-11420-8
摘要

Minimally invasive (robotic or laparoscopic-assisted) nipple-sparing mastectomy combined with prosthesis breast reconstruction (NSM-PBR) is associated with smaller scars and greater patient satisfaction. However, the oncological safety of minimally invasive NSM-PBR remains controversial.This was a retrospective study of patients with breast cancer who underwent breast reconstruction between 1 January 2006 and 20 February 2021. Demographic and clinicopathological characteristics, operation information, postoperative complications, and survival outcomes were analyzed.In all, 292 patients underwent minimally invasive NSM-PBR and 205 underwent open NSM-PBR for breast cancer. In the minimally invasive NSM-PBR group, 268 (91.8%) patients underwent laparoscopy and 24 (8.2%) patients underwent robot-assisted NSM-PBR. Mean operation time in the minimally invasive NSM-PBR group was significantly longer than that in the open NSM-PBR group (P = 0.023). Mean intraoperative blood loss was significantly less in the minimally invasive NSM-PBR group (P < 0.05). There was no significant between-group difference in total complications. Similarly, there were no significant between-group differences in overall survival, recurrence-free survival, and local recurrence rate (P = 0.450, P = 0.613, and P = 0.679, respectively).The complication, recurrence, and mortality rates in minimally invasive NSM-PBR group were comparable to those in open NSM-PBR group. Our preliminary results are encouraging and suggest that minimally invasive NSM-PBR affords good cosmetic results and its oncological safety is comparable to that of open surgery.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wheat完成签到,获得积分10
2秒前
幸运星发布了新的文献求助10
2秒前
3秒前
cdercder应助LOVEME采纳,获得30
4秒前
JDQW完成签到,获得积分10
4秒前
naonao完成签到,获得积分10
4秒前
震动的白山完成签到 ,获得积分10
6秒前
Chancerain发布了新的文献求助10
6秒前
7秒前
7秒前
7秒前
玖月发布了新的文献求助10
7秒前
genesquared完成签到,获得积分10
8秒前
青炀完成签到 ,获得积分10
8秒前
小美酱发布了新的文献求助10
10秒前
yn发布了新的文献求助10
11秒前
Jasper应助gdh采纳,获得30
11秒前
pan完成签到,获得积分10
12秒前
丹青发布了新的文献求助100
12秒前
Seamewww发布了新的文献求助10
12秒前
火星的雪发布了新的文献求助10
13秒前
LingYun发布了新的文献求助10
14秒前
叁肆完成签到,获得积分20
14秒前
研友_xnEOX8发布了新的文献求助10
14秒前
14秒前
传奇3应助Chancerain采纳,获得10
14秒前
田様应助Chancerain采纳,获得10
14秒前
劲秉应助w野采纳,获得30
15秒前
鱼yu发布了新的文献求助10
16秒前
16秒前
在水一方应助yn采纳,获得10
16秒前
ggg发布了新的文献求助20
17秒前
共享精神应助黯然采纳,获得10
17秒前
鹿冶发布了新的文献求助10
18秒前
azure完成签到,获得积分10
18秒前
lucky发布了新的文献求助10
21秒前
zhang完成签到,获得积分10
22秒前
溏心儿发布了新的文献求助10
23秒前
24秒前
Jasper应助海梓采纳,获得10
26秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2500
Востребованный временем 2500
Aspects of Babylonian celestial divination : the lunar eclipse tablets of enuma anu enlil 1500
Agaricales of New Zealand 1: Pluteaceae - Entolomataceae 1040
Healthcare Finance: Modern Financial Analysis for Accelerating Biomedical Innovation 1000
Classics in Total Synthesis IV: New Targets, Strategies, Methods 1000
지식생태학: 생태학, 죽은 지식을 깨우다 600
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 纳米技术 内科学 物理 化学工程 计算机科学 复合材料 基因 遗传学 物理化学 催化作用 细胞生物学 免疫学 电极
热门帖子
关注 科研通微信公众号,转发送积分 3458976
求助须知:如何正确求助?哪些是违规求助? 3053650
关于积分的说明 9037422
捐赠科研通 2742859
什么是DOI,文献DOI怎么找? 1504561
科研通“疑难数据库(出版商)”最低求助积分说明 695334
邀请新用户注册赠送积分活动 694589